Endo Nph Bbi Glucocorticoid Hyperglycemia

Choose NPH-based or basal bolus insulin regimens for glucocorticoid-associated hyperglycemia

STEP 1 — Gather Information

Collect glucocorticoid agent, dose, and schedule (e.g., prednisone 20 mg daily morning); current blood glucose values and trends; diabetes status; current insulin regimen; nutritional status (regular meals, fasting, tube feeds, TPN); renal function and hypoglycemia risk factors (age >65, low BMI, CKD). Proceed to step 2 if hyperglycemia confirmed during glucocorticoid therapy in noncritical illness.

STEP 2 — Rule In / Rule Out

Is the patient experiencing hyperglycemia (e.g., BG >180 mg/dL) while receiving glucocorticoids for a noncritical illness? If YES, proceed to step 3. If NO, glucocorticoid-associated hyperglycemia management not indicated; evaluate other causes or continue routine glucose monitoring.

STEP 3 — Classify or Stratify

Is the patient already on a basal bolus insulin (BBI) regimen? If YES, classify as "BBI-existing" and consider adding NPH. If NO, classify as "BBI-naive" and choose between initiating NPH-based regimen or BBI.

STEP 4 — Decide

For BBI-existing patients, add NPH insulin (with or without prandial insulin) in divided doses matching glucocorticoid pharmacokinetics (e.g., morning NPH for once-daily prednisone); continue basal and prandial insulin as prescribed; monitor BG 4 times daily and adjust doses to avoid hypoglycemia, especially when tapering glucocorticoids. For BBI-naive patients, initiate either: (1) NPH-based regimen: NPH given once or twice daily (aligned with glucocorticoid peaks) ± prandial insulin before meals if eating; or (2) BBI regimen: basal insulin (e.g., glargine) once daily plus rapid-acting prandial insulin before meals plus correctional insulin q4-6h or with meals; select based on patient preference, nursing workload, and glucose variability.

Clinical Guardrails / Mimics / Pitfalls

Do NOT use sliding scale insulin alone; avoid NPH dosing every 8 hours (higher hypoglycemia risk); ensure proper rolling/resuspension of NPH suspensions before administration; do not initiate NPH in patients receiving fasting, TPN, or enteral nutrition (evidence lacking); safeguard against hypoglycemia when glucocorticoids are tapered or discontinued by proactively reducing insulin doses; avoid delaying insulin adjustments despite rising glucose trends.

Concrete Clinical Example

A 60‑year‑old woman with type 2 diabetes on prednisone 40 mg daily for COPD exacerbation develops hyperglycemia (BG 220‑280 mg/dL). She is eating regular meals and currently on metformin only. She is BBI‑naive. Clinician chooses NPH‑based regimen: NPH 10 units at breakfast (to match morning prednisone peak) plus 4 units regular insulin before lunch and dinner. BG checked acutely and before meals; doses titrated to keep BG 100‑180 mg/dL. When prednisone tapered to 20 mg daily, NPH reduced to 6 units to prevent hypoglycemia.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278